Table 1.
Sample | Relative Fluor. Intensity | Decay Parameters | ESS | ETR | EExp.Corr. | 1ETheor.Corr. | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
ID | IDA | τ1 ns | α1 | τ2 ns | α2 | τα | |||||
0.125%RRG380R_Fl | 1 | - | 2.9 | 0.49 | 4.7 | 0.51 | 3.8 | - | - | - | - |
0.04%RRG380R_Fl+0.04%RRG380R_Rh | 1 | 0.91 | 2.9 | 0.54 | 4.7 | 0.46 | 3.7 | 0.09 | 0.03 | 0.06 | 0.06 |
0.15%RRG380R_Fl+0.15%RRG380R_Rh | 1 | 0.75 | 2.4 | 0.49 | 4.3 | 0.51 | 3.4 | 0.25 | 0.11 | 0.14 | 0.14 |
from (4).
Note: ID and IDA are the steady-state relative donor intensities of samples containing only donor-labeled peptides and samples with both donor- and acceptor-labeled peptides, respectively. The amplitude-averaged lifetimes τα are defined by Eq.3. The experimentally corrected FRET efficiency (EExp.Corr.) is calculated as a difference between the total FRET efficiency obtained in a steady-state experiment (ESS) and “proximity” FRET efficiency obtained in a time-resolved experiment (ETR). The relative errors of ESS, ETR and EExp.Corr. were less than 1%, 15% and 10%, respectively. ETheor.Corr. - theoretically corrected FRET efficiency (4)